Literature DB >> 17912593

Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.

Christopher J Sonnenday1, Justin B Dimick, Richard D Schulick, Michael A Choti.   

Abstract

The incidence of hepatocellular carcinoma (HCC) continues to increase, a trend that will likely continue because of the rising prevalence of chronic hepatitis C infection. This study sought to determine the recent patterns of utilization of surgical therapy (hepatectomy, ablation, or liver transplantation) for HCC from the Surveillance, Epidemiology, and End Results national cancer registry. Data were extracted for 16,121 patients with HCC diagnosed between 1998 and 2004. Twenty-three percent of patients underwent surgical therapy (9.5% resection, 7.8% ablation, 6% transplant); the proportion of patients treated with surgical therapy increased approximately 9% over the study period. On multivariate analysis, female sex, younger age, and smaller solitary tumors were associated with increased utilization of surgical therapy. Blacks and Hispanics were 24-27% less likely to receive surgical therapy than white individuals (P<0.001). Racial and geographic disparities persisted despite the adjustment for Health Service Area and limitation of the cohort to small localized HCC. Blacks were especially disadvantaged in the utilization of liver transplant for small HCC (OR=0.42, P<0.001). Further investigation to understand the etiology of these profound racial and geographic disparities is essential to ensure equitable provision of surgical therapies, which provide the only potentially curative treatments for HCC.

Entities:  

Mesh:

Year:  2007        PMID: 17912593     DOI: 10.1007/s11605-007-0315-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  37 in total

1.  Disparity in use of orthotopic liver transplantation among blacks and whites.

Authors:  Andrea E Reid; Maria Resnick; YuChiao Chang; Nathan Buerstatte; Joel S Weissman
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

2.  Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?

Authors:  Francis Y Yao; John P Roberts
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

3.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Prognostic factors for survival in pancreatic cancer: a population-based study.

Authors:  Mohamad A Eloubeidi; Renee A Desmond; C Mel Wilcox; Reda J Wilson; Pavan Manchikalapati; Mona M Fouad; Isam Eltoum; Selwyn M Vickers
Journal:  Am J Surg       Date:  2006-09       Impact factor: 2.565

7.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Authors:  Francis Y Yao; Ryutaro Hirose; Jeanne M LaBerge; Timothy J Davern; Nathan M Bass; Robert K Kerlan; Raphael Merriman; Sandy Feng; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

Review 8.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

9.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

10.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

View more
  28 in total

1.  Frailty as a Risk Predictor of Morbidity and Mortality Following Liver Surgery.

Authors:  Faiz Gani; Marcelo Cerullo; Neda Amini; Stefan Buettner; Georgios A Margonis; Kazunari Sasaki; Yuhree Kim; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-03-06       Impact factor: 3.452

2.  Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.

Authors:  Li Xu; Yuhree Kim; Gaya Spolverato; Faiz Gani; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

3.  Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma.

Authors:  Nader N Massarweh; James O Park; Farhood Farjah; Raymond S W Yeung; Rebecca Gaston Symons; Thomas L Vaughan; Laura-Mae Baldwin; David R Flum
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

4.  Differences in Physician Referral Drive Disparities in Surgical Intervention for Hepatocellular Carcinoma: A Retrospective Cohort Study.

Authors:  Alexis P Chidi; Cindy L Bryce; Larissa Myaskovsky; Michael J Fine; David A Geller; Douglas P Landsittel; Allan Tsung
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

5.  Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.

Authors:  Ricardo A Franco; Yunhua Fan; Stephanie Jarosek; Sejong Bae; James Galbraith
Journal:  Am J Prev Med       Date:  2018-11       Impact factor: 5.043

6.  Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle.

Authors:  Jacqueline M Major; James D Sargent; Barry I Graubard; Heather A Carlos; Albert R Hollenbeck; Sean F Altekruse; Neal D Freedman; Katherine A McGlynn
Journal:  Ann Epidemiol       Date:  2013-11-21       Impact factor: 3.797

7.  Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.

Authors:  Warren H Tseng; Thomas R Stevenson; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold; Steve R Martinez
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

8.  Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.

Authors:  Steve Scaglione; William Adams; Allyce Caines; Pauline Devlin; Sahil Mittal; Amit G Singal; Neehar D Parikh
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

9.  Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.

Authors:  Chenjie Zeng; Wanqing Wen; Alicia K Morgans; William Pao; Xiao-Ou Shu; Wei Zheng
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

10.  Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Authors:  Omar Hyder; Rebecca M Dodson; Hari Nathan; Joseph M Herman; David Cosgrove; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-13       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.